Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening

Pharmacological Research - Tập 52 Số 4 - Trang 313-320 - 2005
K. K. Srinivasan1, Bhoomi Viswanad1, Lydia Asrat1, C. L. Kaul1, Poduri Ramarao1
1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, Phase X, S.A.S. Nagar, Mohali 160 062, Punjab, India.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Saltiel, 1996, Thiazolidinediones in the treatment of insulin resistance and type II diabetes, Diabetes, 45, 1661, 10.2337/diab.45.12.1661

Lebovitz, 2004, Treatment of insulin resistance in diabetes mellitus, Eur J Pharmacol, 490, 135, 10.1016/j.ejphar.2004.02.051

Ramarao, 1999, Insulin resistance: Current therapeutic approaches, Drugs Today, 35, 895, 10.1358/dot.1999.35.12.564037

McIntosh, 1999, Non insulin dependent animal models of diabetes mellitus, 337

Luo, 1998, Nongenetic mouse models of non-insulin-dependent diabetes mellitus, Metabolism, 47, 663, 10.1016/S0026-0495(98)90027-0

Shafrir, 2003, Diabetes in animals: Contribution to the understanding of diabetes by study of its etiopathology in animal models, 231

Rerup, 1970, Drugs producing diabetes through damage of the insulin secreting cells, Pharmacol Rev, 22, 485

Weir, 1981, Islet secretion in a new experimental model for non insulin dependent diabetes, Diabetes, 30, 590, 10.2337/diab.30.7.590

Hofmann, 1991, Glucose transporter deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone, Endocrinology, 129, 1915, 10.1210/endo-129-4-1915

Portha, 1994, Cellular basis for glucose refractoriness of pancreatic B-cells in non insulin dependent diabetes, 461

Storlien, 1986, Fat feeding causes widespread in-vivo insulin resistance, decreased energy expenditure and obesity in the rat, Am J Physiol, 251, E576

Srinivasan, 2004, Reversal of glucose intolerance by pioglitazone in high-fat diet fed rats, Methods Find Exp Clin Pharmacol, 26, 327, 10.1358/mf.2004.26.5.831322

Reed, 2000, A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat, Metabolism, 49, 1390, 10.1053/meta.2000.17721

Reaven, 1991, Low dose streptozotocin induced diabetes in the spontaneously hypertensive rat, Metabolism, 40, 335, 10.1016/0026-0495(91)90141-I

Manchem, 2001, A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo, Diabetes, 50, 824, 10.2337/diabetes.50.4.824

Zhang, 2003, The rat model of type 2 diabetes mellitus and its glycometabolism characters, Exp Anim, 52, 401, 10.1538/expanim.52.401

Reaven, 1991, Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension: parallels between human disease and rodent models, Diabetes Care, 14, 195, 10.2337/diacare.14.3.195

Randle, 1963, The glucose–fatty acid cycle. Its role in insulin sensitivity and metabolic disturbances in diabetes mellitus, Lancet, 1, 785, 10.1016/S0140-6736(63)91500-9

Belfiore, 1998, Insulin resistance in obesity: metabolic mechanisms and measurement methods, Mol Gen Metab, 65, 121, 10.1006/mgme.1998.2727

Iwanishi, 1993, Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats, Metabolism, 42, 1017, 10.1016/0026-0495(93)90016-H

Rosholt, 1994, High-fat diet reduces glucose transporter responses to both insulin and exercise, Am J Physiol, 266, R95

Colca, 1991, Pioglitazone hydrochloride inhibits cholesterol absorption and lowers plasma cholesterol concentrations in cholesterol fed rats, Diabetes, 40, 1669, 10.2337/diab.40.12.1669

Portha, 1995, Pathogenesis of impaired insulin action in rat models of insulin deficiency, 83

Spiegelman, 1998, PPAR γ: Adipogenic regulator and thiazolidinedione receptor, Diabetes, 47, 507, 10.2337/diabetes.47.4.507

Masiello, 1998, Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide, Diabetes, 47, 224, 10.2337/diab.47.2.224

Shafrir, 1992, Animal models of non insulin dependent diabetes, Diab Metab Rev, 8, 179, 10.1002/dmr.5610080302

Schaffer, 1993, Effects of chronic glipizide treatment on the NIDD heart, Horm Metab Res, 25, 348, 10.1055/s-2007-1002117

Reaven, 1983, Effect of glipizide treatment on various aspects of glucose, insulin, and lipid metabolism in patients with non insulin-dependent diabetes mellitus, Am J Med, 30, 8, 10.1016/0002-9343(83)90248-6

Jeppesen, 1994, Effect of glipizide treatment on postprandial lipaemia in patients with NIDDM, Diabetologia, 37, 781, 10.1007/BF00404335

Pascoe, 1990, Inducement by fat feeding of basal hyperglycemia in rats with abnormal beta-cell function. Model for study of etiology and pathogenesis of NIDDM, Diabetes, 39, 226, 10.2337/diab.39.2.226

Gao, 2000, Mechanism of silk hydrates on modulating the blood glucose metabolism in rats with experimental diabetes, Wei Sheng Yan Jiu, 29, 379